3-V Biosciences is a biopharmaceutical company discovering and developing novel therapeutics for the treatment of infectious diseases.
Our goal is to improve human health by innovatively treating viral infections, with a strategy that takes advantage of the critical role host-cells play in viral replication. This approach allows us to eventually treat infectious diseases with new benefits and in novel ways:
Low likelihood for resistance - because viruses are unlikely to overcome their dependency on host targets
Broad spectrum activity - allows effective treatment of all circulating strains of a specific virus with the potential to treat multiple unrelated viruses
Viral illnesses are typically treated using a “One Drug, One Bug” approach. However, multiple unrelated viruses can cause the same clinical syndrome, complicating the diagnosis and treatment of patients. 3-V Biosciences agents allow the potential for a “One Drug, Multiple Bugs” antiviral therapeutic paradigm, analogous to antibiotic treatment of most bacterial infections.